• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

无支气管肺疾病儿童支气管肺泡灌洗液中表面活性物质磷脂和表面活性蛋白A的年龄依赖性

Age-dependency of surfactant phospholipids and surfactant protein A in bronchoalveolar lavage fluid of children without bronchopulmonary disease.

作者信息

Ratjen F, Rehn B, Costabel U, Bruch J

机构信息

Dept of Paediatrics, University of Essen, Germany.

出版信息

Eur Respir J. 1996 Feb;9(2):328-33. doi: 10.1183/09031936.96.09020328.

DOI:10.1183/09031936.96.09020328
PMID:8777972
Abstract

Whilst alterations in surfactant components of bronchoalveolar lavage fluid (BALF) have been described in a variety of pulmonary diseases in adults, no information is available on the surfactant composition in children beyond the neonatal period. In order to obtain reference values for the paediatric age group, we have studied phospholipid profiles of BALF in children without pulmonary disease. The study population consisted of 38 children aged 3-15 yrs (mean +/- SD 8 +/- 4 yrs) undergoing elective surgery for nonpulmonary illnesses. Surfactant composition was analysed by high pressure liquid chromatography using both an ultraviolet and a light-scattering detector. Total phospholipid concentration was higher in children under 8 yrs of age and decreased with age. In contrast, the total protein concentration remained constant throughout the age range. No age-related changes in the relative composition of phospholipid fractions could be observed. Surfactant protein A concentrations were highly variable in all age groups. This study provides the first data on surfactant components in bronchoalveolar lavage fluid of healthy children and will be the basis for future studies of children with pulmonary diseases.

摘要

虽然在多种成人肺部疾病中已描述了支气管肺泡灌洗液(BALF)表面活性剂成分的改变,但关于新生儿期以外儿童的表面活性剂组成尚无相关信息。为了获得儿科年龄组的参考值,我们研究了无肺部疾病儿童BALF的磷脂谱。研究人群包括38名3至15岁(平均±标准差8±4岁)因非肺部疾病接受择期手术的儿童。使用紫外和光散射检测器通过高压液相色谱法分析表面活性剂组成。8岁以下儿童的总磷脂浓度较高,并随年龄增长而降低。相比之下,总蛋白浓度在整个年龄范围内保持恒定。未观察到磷脂组分相对组成的年龄相关变化。表面活性剂蛋白A浓度在所有年龄组中变化很大。本研究提供了健康儿童支气管肺泡灌洗液中表面活性剂成分的首批数据,将作为未来对患有肺部疾病儿童研究的基础。

相似文献

1
Age-dependency of surfactant phospholipids and surfactant protein A in bronchoalveolar lavage fluid of children without bronchopulmonary disease.无支气管肺疾病儿童支气管肺泡灌洗液中表面活性物质磷脂和表面活性蛋白A的年龄依赖性
Eur Respir J. 1996 Feb;9(2):328-33. doi: 10.1183/09031936.96.09020328.
2
Surfactant protein A in bronchoalveolar lavage fluid.支气管肺泡灌洗液中的表面活性物质蛋白A
J Lab Clin Med. 1992 Aug;120(2):252-63.
3
Deficient hydrophilic lung surfactant proteins A and D with normal surfactant phospholipid molecular species in cystic fibrosis.囊性纤维化患者中肺表面活性物质亲水性蛋白A和D缺乏,而表面活性磷脂分子种类正常。
Am J Respir Cell Mol Biol. 1999 Jan;20(1):90-8. doi: 10.1165/ajrcmb.20.1.3253.
4
Surfactant protein-A concentration in bronchoalveolar lavage fluids of patients with pulmonary alveolar proteinosis.肺泡蛋白沉积症患者支气管肺泡灌洗液中表面活性蛋白A的浓度
Chest. 1993 Feb;103(2):496-9. doi: 10.1378/chest.103.2.496.
5
Lung surfactant in a cystic fibrosis animal model: increased alveolar phospholipid pool size without altered composition and surface tension function in cftrm1HGU/m1HGU mice.囊性纤维化动物模型中的肺表面活性剂:cftrm1HGU/m1HGU小鼠肺泡磷脂池大小增加,但组成和表面张力功能未改变
Thorax. 1997 Aug;52(8):723-30. doi: 10.1136/thx.52.8.723.
6
Alteration of surfactant proteins A and D in bronchoalveolar lavage fluid of Pneumocystis carinii pneumonia.卡氏肺孢子虫肺炎支气管肺泡灌洗液体中表面活性蛋白A和D的改变
Chin Med J (Engl). 2001 Nov;114(11):1143-6.
7
Surfactant proteins A and D in children with pulmonary disease due to gastroesophageal reflux.
Am J Respir Crit Care Med. 2002 Jun 1;165(11):1546-50. doi: 10.1164/rccm.2107147.
8
Decreased contents of surfactant proteins A and D in BAL fluids of healthy smokers.健康吸烟者支气管肺泡灌洗液中表面活性蛋白A和D含量降低。
Chest. 1996 Apr;109(4):1006-9. doi: 10.1378/chest.109.4.1006.
9
Altered airway surfactant phospholipid composition and reduced lung function in asthma.哮喘患者气道表面活性物质磷脂成分改变与肺功能降低
J Appl Physiol (1985). 2000 Oct;89(4):1283-92. doi: 10.1152/jappl.2000.89.4.1283.
10
Pulmonary surfactant in cystic fibrosis.囊性纤维化中的肺表面活性物质
Eur Respir J. 1997 Sep;10(9):1983-8. doi: 10.1183/09031936.97.10091983.

引用本文的文献

1
Pathological and Inflammatory Consequences of Aging.衰老的病理和炎症后果
Biomolecules. 2025 Mar 12;15(3):404. doi: 10.3390/biom15030404.
2
Surfactant protein levels and genetic variants as biomarkers for COVID-19 severity in children.表面活性蛋白水平和基因变异作为儿童COVID-19严重程度的生物标志物
Am J Physiol Lung Cell Mol Physiol. 2025 Mar 1;328(3):L350-L356. doi: 10.1152/ajplung.00318.2024. Epub 2025 Jan 20.
3
Comparison of the broncoalveolar lavage fluid proteomics between foals and adult horses.比较驹马和成年马的支气管肺泡灌洗液蛋白质组学。
PLoS One. 2023 Sep 5;18(9):e0290778. doi: 10.1371/journal.pone.0290778. eCollection 2023.
4
Surfactant protein A alters endosomal trafficking of influenza A virus in macrophages.表面活性蛋白 A 改变巨噬细胞中流感 A 病毒的内体运输。
Front Immunol. 2023 Mar 7;14:919800. doi: 10.3389/fimmu.2023.919800. eCollection 2023.
5
SARS-CoV-2 Liability: The Hidden Mystery Behind Its Presentation in Children.SARS-CoV-2 LIABILITY:其在儿童中表现背后的隐藏之谜。
Adv Exp Med Biol. 2021;1353:225-241. doi: 10.1007/978-3-030-85113-2_13.
6
Survival of MS2 and Φ6 viruses in droplets as a function of relative humidity, pH, and salt, protein, and surfactant concentrations.MS2 和 Φ6 病毒在飞沫中随相对湿度、pH 值以及盐、蛋白质和表面活性剂浓度变化的存活情况。
PLoS One. 2020 Dec 8;15(12):e0243505. doi: 10.1371/journal.pone.0243505. eCollection 2020.
7
Severity of Coronavirus Disease 2019 (COVID-19): Does Surfactant Matter?2019冠状病毒病(COVID-19)的严重程度:表面活性剂起作用吗?
Front Microbiol. 2020 Aug 26;11:1905. doi: 10.3389/fmicb.2020.01905. eCollection 2020.
8
Smoking reduces surfactant protein D and phospholipids in patients with and without chronic obstructive pulmonary disease.吸烟会降低慢性阻塞性肺疾病患者和非慢性阻塞性肺疾病患者的表面活性剂蛋白 D 和磷脂。
BMC Pulm Med. 2010 Oct 25;10:53. doi: 10.1186/1471-2466-10-53.